A carregar...
Mass Balance Study of the Engineered Cationic Antimicrobial Peptide, WLBU2, Following a Single Intravenous Dose of 14C-WLBU2 in Mice
BACKGROUND: To address multidrug resistance, we developed engineered cationic antimicrobial peptides (eCAPs). Lead eCAP WLBU2 displays potent activity against drug-resistant bacteria and effectively treats lethal bacterial infections in mice, reducing bacterial loads to undetectable levels in divers...
Na minha lista:
| Publicado no: | Curr Rev Clin Exp Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8083974/ https://ncbi.nlm.nih.gov/pubmed/32778037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1574884715666200810094201 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|